These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 4117256

  • 21. Clinical pharmacology of anticancer drugs.
    Chabner BA, Myers CE, Oliverio VT.
    Semin Oncol; 1977 Jun; 4(2):165-91. PubMed ID: 69319
    [No Abstract] [Full Text] [Related]

  • 22. Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy.
    Mayo JG, Laster WR, Andrews CM, Schabel FM.
    Cancer Chemother Rep; 1972 Apr; 56(2):183-95. PubMed ID: 5043226
    [No Abstract] [Full Text] [Related]

  • 23. [Cytostatic chemotherapy in lymphogranulomatosis].
    Stacher A.
    Med Klin; 1973 Jul 27; 68(30):985-8. PubMed ID: 4131695
    [No Abstract] [Full Text] [Related]

  • 24. The role of chemotherapy in the treatment of lung cancer.
    Selawry OS.
    Semin Oncol; 1974 Sep 27; 1(3):259-72. PubMed ID: 4143488
    [No Abstract] [Full Text] [Related]

  • 25. Chemotherapy for lung cancer at the Institute of Experimental and Clinical Oncology, Academy of Medical Sciences, USSR.
    Perevodchikova NI, Bychkov MB.
    Cancer Chemother Rep 3; 1973 Mar 27; 4(2):251-5. PubMed ID: 4199645
    [No Abstract] [Full Text] [Related]

  • 26. Effect of CCNU (NSC-79037) on bronchogenic carcinoma.
    Takita H, Brugarolas A.
    J Natl Cancer Inst; 1973 Jan 27; 50(1):49-53. PubMed ID: 4348225
    [No Abstract] [Full Text] [Related]

  • 27. A combination of adriamycin, CCNU and hydroxyurea in the treatment of disseminated bronchogenic carcinoma.
    Alberto P, Barrelet L, Chapuis B, Garcia B.
    Eur J Cancer (1965); 1975 Nov 27; 11(11):795-9. PubMed ID: 767111
    [No Abstract] [Full Text] [Related]

  • 28. Monochemotherapy of bronchogenic carcinoma withs special reference to cell type.
    Selawry OS.
    Cancer Chemother Rep 3; 1973 Mar 27; 4(2):177-88. PubMed ID: 4277763
    [No Abstract] [Full Text] [Related]

  • 29. A phase 2 study of intermittent high dose isophosphamide therapy of advanced colorectal cancer.
    Kovach JS, Schutt AJ, Hahn RG, Reitemeier RJ, Moertel CG.
    Oncology; 1974 Mar 27; 29(1):34-9. PubMed ID: 4837137
    [No Abstract] [Full Text] [Related]

  • 30. Current status of new agents.
    Carter SK.
    Cancer Chemother Rep 3; 1972 May 27; 3(1):33-47. PubMed ID: 4116662
    [No Abstract] [Full Text] [Related]

  • 31. Nitrosourea combinations in lung cancer.
    Livingston RB.
    Cancer Treat Rep; 1976 Jun 27; 60(6):757-760. PubMed ID: 182365
    [Abstract] [Full Text] [Related]

  • 32. Combination chemotherapy of bronchogenic carcinoma with cyclophosphamide (NSC-26271) and BCNU (NSC-409962).
    Curtis JE.
    Cancer Chemother Rep; 1974 Jun 27; 58(6):883-8. PubMed ID: 4614897
    [No Abstract] [Full Text] [Related]

  • 33. The sensitivity to cytotoxic agents of the EMT6 tumor in vivo. Comparative response of lung nodules in rapid expotential growth and of the solid flank tumour.
    Twentyman PR, Bleehen NM.
    Br J Cancer; 1976 Mar 27; 33(3):320-8. PubMed ID: 57788
    [Abstract] [Full Text] [Related]

  • 34. Effectiveness of clinically active antineoplastic drugs in a surgical-adjuvant chemotherapy treatment regimen using the Lewis Lung (LL) carcinoma.
    Merker PC, Wodinsky I, Cantor ML, Venditti JM.
    Int J Cancer; 1978 Apr 15; 21(4):482-9. PubMed ID: 78911
    [No Abstract] [Full Text] [Related]

  • 35. New antineoplastic drugs and their proper use.
    Cohen FB, Lippman AJ, Custodio MC, Decter JA.
    Med Clin North Am; 1976 Sep 15; 60(5):959-70. PubMed ID: 59843
    [No Abstract] [Full Text] [Related]

  • 36. Intensive combined chemotherapy and radiotherapy in patients with nonresectable bronchogenic carcinoma.
    Hansen HH, Muggia FM, Andrews R, Selawry OS.
    Cancer; 1972 Aug 15; 30(2):315-24. PubMed ID: 4559404
    [No Abstract] [Full Text] [Related]

  • 37. Clinical pharmacology of isophosphamide.
    Creaven PJ, Allen LM, Alford DA, Cohen MH.
    Clin Pharmacol Ther; 1974 Jul 15; 16(1):77-86. PubMed ID: 4602057
    [No Abstract] [Full Text] [Related]

  • 38. Solid tumor chemotherapy: new drugs and horizons.
    Yardumian H.
    J Am Osteopath Assoc; 1974 Dec 15; 74(4):299-306. PubMed ID: 4140203
    [No Abstract] [Full Text] [Related]

  • 39. [Treatment of small-cell bronchogenic carcinoma with a combination of chemotherapy and irradiation (author's transl)].
    Dundalek E.
    Prax Klin Pneumol; 1980 Dec 15; 34(12):719-23. PubMed ID: 7465532
    [No Abstract] [Full Text] [Related]

  • 40. Phase II multicentre study of the nitrosourea fotemustine in inoperable squamous cell lung carcinoma.
    Le Chevalier T, Zabbe C, Gouva S, Cerrina ML, Quoix E, Riviere A, Berthaud P, Prache C, Berille J.
    Eur J Cancer Clin Oncol; 1989 Nov 15; 25(11):1651-2. PubMed ID: 2687005
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.